Bright Green Corp (BGXXQ) Financial Statements (2025 and earlier)

Company Profile

Business Address 401 EAST LAS OLAS BLVD.
FT. LAUDERDALE, FL 33301
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2024
MRQ
12/31/2023
12/31/2022
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10,059414,574
Cash and cash equivalent10,059414,574
Other undisclosed current assets258,23077,847
Total current assets:268,289492,421
Noncurrent Assets
Property, plant and equipment16,407,41517,146,325
Long-term investments and receivables  3,990,960
Long-term investments  3,990,960
Intangible assets, net (including goodwill)1,0001,000
Intangible assets, net (excluding goodwill)1,0001,000
Deposits noncurrent assets  1,157,587
Other undisclosed noncurrent assets 726,343 
Total noncurrent assets:17,134,75822,295,872
TOTAL ASSETS:17,403,04722,788,293
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,586,3195,481,156
Accounts payable4,175,2205,033,831
Accrued liabilities411,099447,325
Due to related parties392,194
Other undisclosed current liabilities1,650,0001,650,000
Total current liabilities:6,236,3197,523,350
Noncurrent Liabilities
Long-term debt and lease obligation 201,7833,686,107
Long-term debt, excluding current maturities 201,7833,686,107
Total noncurrent liabilities: 201,7833,686,107
Total liabilities:6,438,10211,209,457
Equity
Equity, attributable to parent10,964,94511,578,836
Common stock18,47617,329
Additional paid in capital58,149,93845,637,328
Accumulated deficit(47,203,469)(34,075,821)
Total equity:10,964,94511,578,836
TOTAL LIABILITIES AND EQUITY:17,403,04722,788,293

Income Statement (P&L) (USD)

9/30/2024
TTM
12/31/2023
12/31/2022
Operating expenses(8,891,380)(27,313,922)
Operating loss:(8,891,380)(27,313,922)
Nonoperating income (expense)(1,625) 
Gain (loss), foreign currency transaction, before tax(1,625) 
Interest and debt expense  
Loss from continuing operations before equity method investments, income taxes:(8,893,005)(27,313,922)
Other undisclosed loss from continuing operations before income taxes(4,015,980)(213,000)
Loss from continuing operations before income taxes:(12,908,985)(27,526,922)
Income tax benefit 3,096,3807,037,059
Other undisclosed loss from continuing operations (3,096,380)(7,037,059)
Net loss:(12,908,985)(27,526,922)
Other undisclosed net loss attributable to parent(218,663)(135,155)
Net loss available to common stockholders, diluted:(13,127,648)(27,662,077)

Comprehensive Income (USD)

9/30/2024
TTM
12/31/2023
12/31/2022
Net loss:(12,908,985)(27,526,922)
Comprehensive loss, net of tax, attributable to parent:(12,908,985)(27,526,922)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: